Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings

References

• Falk R H, Comenzo R L, Skinner M. The systemic amyloidoses. N Engl J Med 1997; 337: 898–909
   PubMed Web of Science ®Google Scholar
• Obici L, Perfetti V, Palladini G, Moratti R, Merlini G. Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta 2005; 1753: 11–22
   PubMed Web of Science ®Google Scholar
• Fattori R, Rocchi G, Celletti F, Bertaccini P, Rapezzi C, Gavelli G. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J 1998; 136: 824–830
   PubMed Web of Science ®Google Scholar
• Maceira A M, Joshi J, Prasad S K, Moon J C, Perugini E, Harding I, Sheppard M N, Poole Wilson P A, Hawkins P N, Pennell D J. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005; 111: 186–193
   PubMed Web of Science ®Google Scholar
• Perugini E, Rapezzi C, Piva T, Leone O, Reggiani L B, Riva L, Salvi F, Lovato L, Branzi A, Fattori R. Noninvasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 2006; 92: 343–349
   PubMed Web of Science ®Google Scholar
• Hosch W, Bock M, Libicher M, Ley S, Hegenbart U, Dengler T J, Katus H A, Kauczor H U, Kauffmann G W, Kristen A V. MR-Relaxometry of Myocardial Tissue: Significant Elevation of T1 and T2 Relaxation Times in Cardiac Amyloidosis. Invest Radiol 2007; 42: 636–642
   PubMedGoogle Scholar
• Celletti F, Fattori R, Napoli G, Leone O, Rocchi G, Bacchi-Reggiani L, Gavelli G. Assessment of restrictive cardiomyopathy of amyloid or idiopathic etiology by magnetic resonance imaging. Am J Cardiol 1999; 83: 798–801, A10
   PubMed Web of Science ®Google Scholar
• Mueller P S, Edwards W D, Gertz M A. Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis. Am J Med 2000; 109: 181–188
   PubMed Web of Science ®Google Scholar
• Strege R J, Saeger W, Linke R P. Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series. Virchows Arch 1998; 433: 19–27
   PubMedGoogle Scholar
• Altland K, Benson M D, Costello C E, Ferlini A, Hazenberg B P, Hund E, Kristen A V, Linke R P, Merlini G, Salvi F, Saraiva M J, Singer R, Skinner M, Winter P. Genetic microheterogeneity of human transthyretin detected by IEF. Electrophoresis 2007; 28: 2053–2064
   PubMed Web of Science ®Google Scholar
• Declaration of Helsinki. Recommendations guiding doctors in clinical research. Adopted by the World Medical Association in 1964. Wiss Med J 1967; 66: 25–26
   Google Scholar
• Edelman R R. Contrast-enhanced MR imaging of the heart: overview of the literature. Radiology 2004; 232: 653–668
   PubMed Web of Science ®Google Scholar
• vanden Driesen R I, Slaughter R E, Strugnell W E. MR findings in cardiac amyloidosis. AJR Am J Roentgenol 2006; 186: 1682–1685
   Google Scholar
• Shan K, Constantine G, Sivananthan M, Flamm S D. Role of cardiac magnetic resonance imaging in the assessment of myocardial viability. Circulation 2004; 109: 1328–1334
   PubMed Web of Science ®Google Scholar
• Lima J A, Judd R M, Bazille A, Schulman S P, Atalar E, Zerhouni E A. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 1995; 92: 1117–1125
   PubMed Web of Science ®Google Scholar
• Lim R P, Srichai M B, Lee V S. Non-ischemic causes of delayed myocardial hyperenhancement on MRI. AJR Am J Roentgenol 2007; 188: 1675–1681
   Google Scholar
• Moon J C, Reed E, Sheppard M N, Elkington A G, Ho S Y, Burke M, Petrou M, Pennell D J. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 43: 2260–2264
   PubMed Web of Science ®Google Scholar
• Kim R J, Chen E L, Lima J A, Judd R M. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996; 94: 3318–3326
   PubMed Web of Science ®Google Scholar
• Dispenzieri A, Kyle R A, Gertz M A, Therneau T M, Miller W L, Chandrasekaran K, McConnell J P, Burritt M F, Jaffe A S. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 2003; 361: 1787–1789
   PubMed Web of Science ®Google Scholar
• McCrohon J A, Moon J C, Prasad S K, McKenna W J, Lorenz C H, Coats A J, Pennell D J. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003; 108: 54–59
   PubMed Web of Science ®Google Scholar
• Kim R J, Fieno D S, Parrish T B, Harris K, Chen E L, Simonetti O, Bundy J, Finn J P, Klocke F J, Judd R M. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992–2002
   PubMed Web of Science ®Google Scholar
• Kim R J, Wu E, Rafael A, Chen E L, Parker M A, Simonetti O, Klocke F J, Bonow R O, Judd R M. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445–1453
   PubMed Web of Science ®Google Scholar
• Weber K T, Sun Y, Campbell S E. Structural remodelling of the heart by fibrous tissue: role of circulating hormones and locally produced peptides. Eur Heart J 1995; 16(Suppl. N)12–18
   Google Scholar
• Alloni A, Pellegrini C, Ragni T, Goggi C, D'Armini A M, Rinaldi M, Vigano M. Heart transplantation in patients with amyloidosis: single-center experience. Transplant Proc 2004; 36: 643–644
   Google Scholar
• Maurer M S, Raina A, Hesdorffer C, Bijou R, Colombo P, Deng M, Drusin R, Haythe J, Horn E, Lee S H, Marboe C, Naka Y, Schulman L, Scully B, Shapiro P, Prager K, Radhakrishnan J, Restaino S, Mancini D. Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure. Transplantation 2007; 83: 539–545
   PubMed Web of Science ®Google Scholar
• Gillmore J D, Goodman H J, Lachmann H J, Offer M, Wechalekar A D, Joshi J, Pepys M B, Hawkins P N. Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis. Blood 2006; 107: 1227–1229
   PubMed Web of Science ®Google Scholar
• Dubrey S W, Burke M M, Hawkins P N, Banner N R. Cardiac transplantation for amyloid heart disease: The United Kingdom experience. J Heart Lung Transplant 2004; 23: 1142–1153
   PubMed Web of Science ®Google Scholar
• Vogel-Claussen J, Rochitte C E, Wu K C, Kamel I R, Foo T K, Lima J A, Bluemke D A. Delayed enhancement MR imaging: utility in myocardial assessment. Radiographics 2006; 26: 795–810
   Google Scholar